**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 7440-43-9 |Cadmium | 0.1 | 231-152-8 |
|----------------|--------------------------------------|----------|-----------|
| 7697-37-2 |Nitric acid | 3.15 | 231-714-2 |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | 96.75 | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN N
Risk Phrases: 20/21/22 37/38 41 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to respiratory system and skin. Risk of serious damage to
eyes. Very toxic to aquatic organisms, may cause long-term adverse
effects in the aquatic environment.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal
damage.
Skin:
Causes skin irritation.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
Causes respiratory tract irritation.
Chronic:
Effects may be delayed. Chronic inhalation of cadmium compounds has
been associated with lung and prostate cancer. Cadmium and compounds
may cause lung, liver and kidney damage and lung and prostate cancer
in humans.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Get medical aid immediately. Do NOT allow victim to rub eyes or keep
eyes closed. Extensive irrigation with water is required (at least 30
minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use
extinguishing media appropriate to the surrounding fire. Substance is
noncombustible. Vapors may be heavier than air. They can spread
along the ground and collect in low or confined areas.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Use only in a well-ventilated area. Do not breathe dust, vapor,
mist, or gas. Do not get in eyes, on skin, or on clothing. Keep
container tightly closed. Do not ingest or inhale. Discard
contaminated shoes.
Storage:
Keep container closed when not in use. Store in a cool, dry,
well-ventilated area away from incompatible substances. Corrosives
area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low. See 29CFR 1910.1027
for regulations applying to all occupational exposures to cadmium and
cadmium compounds, in all forms.
Exposure Limits
CAS# 7440-43-9:
United Kingdom, WEL - TWA: 0.025 mg/m3 TWA
United Kingdom, WEL - STEL: 0.075 mg/m3 STEL
United States OSHA: 0.2 mg/m3 TWA (dust); 0.1 mg/m3 TWA (fume); 0
mg/m3 Ceiling (dust); 0.3 mg/m3 Ceiling (fume); 2.5 ??g/m3 Action
Level; 5 ??g/m3 TWA (Do not eat, drink or chew tobacco or gum or
apply cosmetics in regulated areas. Carcinogen - dust can cause l
and kidn
Belgium - TWA: 0.002 mg/m3 VLE (respirable particulates); 0.01 mg
VLE (inhalable particulate
France - VME: 0.05 mg/m3 VME
Germany: 0.03 mg/m3 TWA (dusts/aerosols, inhalable fraction, batt
production - thermal
Japan: 0.05 mg/m3 OEL
Malaysia: 0.01 mg/m3 TWA; 0.002 mg/m3 TWA (respirable fraction)
Netherlands: (listed as chromium compounds): 0.01 mg/m3 STEL
Netherlands: 0.005 mg/m3 MAC
Russia: 0.05 mg/m3 TWA
Russia: 0.01 mg/m3 STEL
Spain: 0.01 mg/m3 VLA-ED (inhalable fraction); 0.002 mg/m3 VLA-ED
(respirable fraction)
CAS# 7697-37-2:
United Kingdom, WEL - TWA: 2 ppm TWA; 5.2 mg/m3 TWA
United Kingdom, WEL - STEL: 4 ppm STEL; 10 mg/m3 STEL
United States OSHA: 2 ppm TWA; 5 mg/m3 TWA
Belgium - TWA: 2 ppm VLE; 5.3 mg/m3 VLE
Belgium - STEL: 4 ppm VLE; 10 mg/m3 VLE
France - VME: 2 ppm VME; 5 mg/m3 VME
France - VLE: 4 ppm VLE; 10 mg/m3 VLE
Germany: 2 ppm TWA; 5.2 mg/m3 TWA
Japan: 2 ppm OEL; 5.2 mg/m3 OEL
Malaysia: 2 ppm TWA; 5.2 mg/m3 TWA
Netherlands: 0.5 ppm STEL; 1.3 mg/m3 STEL
Russia: 2 mg/m3 TWA
Spain: 2 ppm VLA-ED; 5.2 mg/m3 VLA-ED
Spain: 4 ppm VLA-EC; 10 mg/m3 VLA-EC
CAS# 7732-18-5:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: miscible
Specific Gravity/Density: >1.0
Molecular Formula: Solution
Molecular Weight: 0
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Strong bases, strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, irritating and toxic fumes and gases, nitrogen,
cadmium fumes.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7440-43-9: EU9800000
CAS# 7697-37-2: QU5775000 QU5900000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
CAS# 7440-43-9: Inhalation, rat: LC50 = 25 mg/m3/30M; Oral, mouse:
LD50 = 890 mg/kg; Oral, rat: LD50 = 2330 mg/kg.
CAS# 7697-37-2: Inhalation, rat: LC50 = 260 mg/m3/30M; Inhalation,
rat: LC50 = 130 mg/m3/4H; Inhalation, rat: LC50 = 67 ppm(NO2)/4H.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Cadmium -
ACGIH: A2 - Suspected Human Carcinogen (listed as Cadmium compoun
California: carcinogen, initial date 10/1/87
NTP: Known carcinogen
IARC: Group 1 carcinogen
Nitric acid -
Not listed by ACGIH, IARC, or NTP.
Water -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing Group: II
IMO
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing Group: II
RID/ADR
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing group: II
USA RQ: CAS# 7440-43-9: 10 lb final RQ (no reporting of releases of this hazardo
USA RQ: CAS# 7697-37-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN N
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 37/38 Irritating to respiratory system and skin.
R 41 Risk of serious damage to eyes.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 7440-43-9: No information available.
CAS# 7697-37-2: 1
CAS# 7732-18-5: No information available.
Canada
CAS# 7440-43-9 is listed on Canada's DSL List.
CAS# 7697-37-2 is listed on Canada's DSL List.
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 7440-43-9 is listed on Canada's Ingredient Disclosure List.
CAS# 7697-37-2 is listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7440-43-9 is listed on the TSCA inventory.
CAS# 7697-37-2 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
4-Dimethylaminoantipyrine, 97%
| 58-15-1 |
|
(R)-(-)-1-Phenyl-1,2-Ethanediol, 99+%
| 16355-00-3 |
|
Triethylphenylammonium Hydroxide (10% in Water)
| 7620-71-5 |
|
4-Aminophenol Hydrochloride, 98% (UV-Vis)
| 51-78-5 |
|
N-Butylaniline,99%
| 1126-78-9 |
|
4-Chlorobutyryl chloride, 98%
| 4635-59-0 |
|
2-Ethyl-2-Hydroxybutyric Acid, 99%
| 3639-21-2 |
|
Methyl phenyl disulfide, 97+%
| 14173-25-2 |
|
1-Nitropyrene, 99%
| 5522-43-0 |
|
1-Hexadecanesulfonyl chloride, 98%
| 38775-38-1 |
|
M-Phenylene Dibenzoate
| 94-01-9 |
|
5-Methyl-1H-benzotriazole(1,2,3), 98%
| 136-85-6 |
|
1,4-Cyclohexanediol (Pract)
| 556-48-9 |
|
3-Nitrobenzamidine hydrochloride, 97%
| 56406-50-9 |
|
Tris-(3-(Heptafluoropropylhydroxymethylene )-D-Camphorato), Eu (III)
| 34788-82-4 |
|
2,3-Diphenylquinoxaline, 99+% (titr.)
| 1684-14-6 |
|
2-Isopropyl-3-Methoxypyrazine, 97%
| 25773-40-4 |
|
Cadmium fluoride, 99.99+%
| 7790-79-6 |
|
2,2,4-Trichlorobutanal, 97%
| 0-01-1 |
|
2-Fluorenecarboxaldehyde, 99%
| 30084-90-3 |
|
Calcein blue, indicator grade
| 54375-47-2 |
|
Tetraester 4-Tert-Butylcalix(4)Arene, 95% (TLC)
| 0-01-1 |
|
4-Fluorobenzotrifluoride, 97%
| 402-44-8 |
|
1-Oxo-Octyl-Beta-D-Glucoside, 99+%
| 0-01-1 |
|
Arecoline Hydrobromide, 99+%
| 300-08-3 |
|
Dl-2-amino-3-methyl-1-butanol, 95% (gc)
| 16369-05-4 |
|
4-Fluorobenzenesulfonyl Chloride, 98%
| 349-88-2 |
|
Telluroxanthone, 99+%
| 72294-67-8 |
|
Triethanolamine borate, 95+% (ex nitrogen)
| 15277-97-1 |
|
Acetyl-Beta-Methylcholine Bromide, 99%
| 333-31-3 |
|
2,4-Dimethylimidazole, Tech.,90%
| 930-62-1 |
|
Dl-3-methylcyclopentanone, 99%
| 1757-42-2 |
|
Cadmium atomic absorption standard solution, 1 mg/ml Cd in 0.5N HNO3
| 7440-43-9 |
|
3,3'-Diethyloxadicarbocyanine Iodide, 98% (UV-Vis)
| 14806-50-9 |
|
2-(2-(2-Methoxyethoxy)ethoxy)-1,3-Dioxola-ne, 97%
| 74733-99-6 |
|
3,4-Difluorobenzoyl chloride, 98%
| 76903-88-3 |
|
4-Methylsulphonyl Benzaldehyde, 95+%
| 5398-77-6 |
|
N,N'-Bis(3-Aminopropyl)Ethylenediamine, 96.5+% (GC)
| 10563-26-5 |
|
4-Amino-Alpha-Diethylamino-Ortho-Cresol Dihydrochloride, 97%
| 6297-14-9 |
|
Polyvinylpyrrolidone-iodine complex
| 25655-41-8 |
|
2,3,3-Trimethyl-1-butene, 99+%
| 594-56-9 |
|
N-Cyclohexyl-2-pyrrolidone, 99%
| 6837-24-7 |
|
Fluorobenzene-d5, 98+ atom % D
| 1423-10-5 |
|
DL-alpha-Tocopheryl acetate, 98%
| 7695-91-2 |
|
Methyl-d3 alcohol-d, 99.5 atom % D
| 67-56-1 |
|
Didodecylamine (Pract)
| 3007-31-6 |
|
3-Hexylthiophene, 99+%
| 1693-86-3 |
|
N-Methylbenzamide, 99+%
| 613-93-4 |
|
4,4'-Difluorobenzophenone, 99%
| 345-92-6 |
|
1-Fluoronaphthalene, 98%
| 321-38-0 |
|
|